Income Opportunity Realty (AMEX:IOR) reported quarterly earnings of $0.20 per share. This is unchanged from the same period last year.
HC Wainwright & Co. Maintains Buy on Fate Therapeutics, Raises Price Target to $121
HC Wainwright & Co. analyst Robert Burns maintains Fate Therapeutics (NASDAQ:FATE) with a Buy and raises the price target from $120 to $121.